These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 18256938)

  • 1. The emerging role of anti-angiogenic therapy for malignant glioma.
    Reardon DA; Desjardins A; Rich JN; Vredenburgh JJ
    Curr Treat Options Oncol; 2008 Feb; 9(1):1-22. PubMed ID: 18256938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms.
    Miletic H; Niclou SP; Johansson M; Bjerkvig R
    Expert Opin Ther Targets; 2009 Apr; 13(4):455-68. PubMed ID: 19335067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy.
    Reardon DA; Wen PY; Desjardins A; Batchelor TT; Vredenburgh JJ
    Expert Opin Biol Ther; 2008 Apr; 8(4):541-53. PubMed ID: 18352856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic therapy in glioma.
    Butowski N
    Clin Transl Oncol; 2011 May; 13(5):294-300. PubMed ID: 21596656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic approaches to malignant gliomas.
    Soffietti R; Trevisan E; Bertero L; Bosa C; Ruda R
    Curr Cancer Drug Targets; 2012 Mar; 12(3):279-88. PubMed ID: 22229250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel anti-angiogenic therapies for malignant gliomas.
    Norden AD; Drappatz J; Wen PY
    Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic Therapy of High-Grade Gliomas.
    Jo J; Wen PY
    Prog Neurol Surg; 2018; 31():180-199. PubMed ID: 29393186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
    Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
    Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas.
    Argyriou AA; Giannopoulou E; Kalofonos HP
    Oncology; 2009; 77(1):1-11. PubMed ID: 19439998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.
    Lu-Emerson C; Duda DG; Emblem KE; Taylor JW; Gerstner ER; Loeffler JS; Batchelor TT; Jain RK
    J Clin Oncol; 2015 Apr; 33(10):1197-213. PubMed ID: 25713439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiangiogenic therapy in malignant glioma: promise and challenge.
    Sathornsumetee S; Rich JN
    Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic therapy for high-grade gliomas: current concepts and limitations.
    De Bonis P; Marziali G; Vigo V; Peraio S; Pompucci A; Anile C; Mangiola A
    Expert Rev Neurother; 2013 Nov; 13(11):1263-70. PubMed ID: 24175724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic strategies for treatment of malignant gliomas.
    Chi AS; Norden AD; Wen PY
    Neurotherapeutics; 2009 Jul; 6(3):513-26. PubMed ID: 19560741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis and antiangiogenic therapy for malignant gliomas.
    Takano S; Kamiyama H; Tsuboi K; Matsumura A
    Brain Tumor Pathol; 2004; 21(2):69-73. PubMed ID: 15700836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-angiogenic role of soluble-form VEGF receptor in malignant gliomas.
    Takano S; Ishikawa E; Matsuda M; Sakamoto N; Akutsu H; Yamamoto T; Matsumura A
    Int J Oncol; 2017 Feb; 50(2):515-524. PubMed ID: 28000842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
    Wong ML; Prawira A; Kaye AH; Hovens CM
    J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic therapy in malignant gliomas.
    Norden AD; Drappatz J; Wen PY
    Curr Opin Oncol; 2008 Nov; 20(6):652-61. PubMed ID: 18841047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-angiogenic therapy for malignant glioma].
    Nagane M
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):141-7. PubMed ID: 24743191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.